7-122302008-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001024613.4(FEZF1):c.1417G>A(p.Gly473Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000278 in 1,439,938 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001024613.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FEZF1 | NM_001024613.4 | c.1417G>A | p.Gly473Ser | missense_variant | 4/4 | ENST00000442488.7 | NP_001019784.2 | |
FEZF1 | NM_001160264.2 | c.1267G>A | p.Gly423Ser | missense_variant | 5/5 | NP_001153736.1 | ||
FEZF1 | XM_005250337.4 | c.1417G>A | p.Gly473Ser | missense_variant | 5/5 | XP_005250394.1 | ||
FEZF1 | XM_011516202.3 | c.1267G>A | p.Gly423Ser | missense_variant | 6/6 | XP_011514504.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FEZF1 | ENST00000442488.7 | c.1417G>A | p.Gly473Ser | missense_variant | 4/4 | 1 | NM_001024613.4 | ENSP00000411145 | P2 | |
FEZF1 | ENST00000427185.2 | c.1267G>A | p.Gly423Ser | missense_variant | 5/5 | 1 | ENSP00000392727 | A2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000438 AC: 1AN: 228160Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 125952
GnomAD4 exome AF: 0.00000278 AC: 4AN: 1439938Hom.: 0 Cov.: 31 AF XY: 0.00000279 AC XY: 2AN XY: 716552
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 30, 2023 | The c.1417G>A (p.G473S) alteration is located in exon 4 (coding exon 4) of the FEZF1 gene. This alteration results from a G to A substitution at nucleotide position 1417, causing the glycine (G) at amino acid position 473 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at